Literature DB >> 10390126

Role and regulation of cyclooxygenase-2 during inflammation.

L S Simon1.   

Abstract

Prostaglandins are formed from arachidonic acid by the action of cyclooxygenase (COX) and subsequent downstream synthetases. Recently, it has been found that there are two closely related forms of COX, which are now known as COX-1 and COX-2. Although both isoforms of this enzyme convert arachidonate to prostaglandins, there are significant differences in their distribution in the body and their roles in health and disease. The basis for these important differences lies in the genes for COX-1 and COX-2 and the regulation of these genes. COX-1, the predominantly constitutive form of the enzyme, is expressed throughout the body and provides certain homeostatic functions, such as maintaining normal gastric mucosa, influencing renal blood flow, and aiding in blood clotting by abetting platelet aggregation. In contrast, COX-2, the inducible form, is expressed in response to inflammatory and other physiologic stimuli and growth factors and is involved in the production of those prostaglandins that mediate pain and support the inflammatory process. All conventional nonsteroidal anti-inflammatory drugs (NSAIDs) nonspecifically inhibit both COX-1 and COX-2 at standard anti-inflammatory doses. The beneficial anti-inflammatory and analgesic effects occur through the inhibition of COX-2, but the gastrointestinal toxicities and the mild bleeding diathesis occur as a result of concurrent inhibition of COX-1. It is important that physicians fully understand the pharmacologic basis for the differential actions of NSAIDs when prescribing them for pain and inflammation. This understanding is also important so that physicians can critically evaluate the basis for, and the emerging data on, COX-2-specific inhibitors and their potential role in clinical medicine. Agents that would inhibit COX-2 while sparing COX-1 represent an attractive therapeutic development and could represent a major advance in the treatment of rheumatoid arthritis and osteoarthritis, as well as a diverse array of other conditions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10390126     DOI: 10.1016/s0002-9343(99)00115-1

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  67 in total

1.  Differences in genetic signaling, and not mechanical properties of the wall, are linked to ascending aortic aneurysms in fibulin-4 knockout mice.

Authors:  Jungsil Kim; Jesse D Procknow; Hiromi Yanagisawa; Jessica E Wagenseil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-05-01       Impact factor: 4.733

Review 2.  Implications of polyadenylation in health and disease.

Authors:  Ana Curinha; Sandra Oliveira Braz; Isabel Pereira-Castro; Andrea Cruz; Alexandra Moreira
Journal:  Nucleus       Date:  2014-10-31       Impact factor: 4.197

3.  Suppression of von Hippel-Lindau Protein in Fibroblasts Protects against Bleomycin-Induced Pulmonary Fibrosis.

Authors:  Qiyuan Zhou; Tianji Chen; Wei Zhang; Melike Bozkanat; Yongchao Li; Lei Xiao; Richard B van Breemen; John W Christman; Jacob I Sznajder; Guofei Zhou
Journal:  Am J Respir Cell Mol Biol       Date:  2016-05       Impact factor: 6.914

4.  Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer.

Authors:  C Costa; R Soares; J S Reis-Filho; D Leitão; I Amendoeira; F C Schmitt
Journal:  J Clin Pathol       Date:  2002-06       Impact factor: 3.411

5.  Transcription factor Ets-1 inhibits glucose-stimulated insulin secretion of pancreatic β-cells partly through up-regulation of COX-2 gene expression.

Authors:  Xiong-Fei Zhang; Yi Zhu; Wen-Biao Liang; Jing-Jing Zhang
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

Review 6.  Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis.

Authors:  O C Trifan; T Hla
Journal:  J Cell Mol Med       Date:  2003 Jul-Sep       Impact factor: 5.310

Review 7.  Different mechanisms in formation and prevention of indomethacin-induced gastric ulcers.

Authors:  Halis Suleyman; Abdulmecit Albayrak; Mehmet Bilici; Elif Cadirci; Zekai Halici
Journal:  Inflammation       Date:  2010-08       Impact factor: 4.092

Review 8.  Sumatriptan-naproxen fixed combination for acute treatment of migraine: a critical appraisal.

Authors:  Chaouki K Khoury; James R Couch
Journal:  Drug Des Devel Ther       Date:  2010-02-18       Impact factor: 4.162

9.  Selective COX-2 inhibition is associated with decreased mucosal damage induced by acid and pepsin in rabbit esophagitis.

Authors:  Angel Lanas; Pilar Jiménez; Angel Ferrández; Alfredo Escartín; Juan Arenas; Francisco Esteva; Javier Ortego
Journal:  Inflammation       Date:  2003-02       Impact factor: 4.092

Review 10.  CYP4 enzymes as potential drug targets: focus on enzyme multiplicity, inducers and inhibitors, and therapeutic modulation of 20-hydroxyeicosatetraenoic acid (20-HETE) synthase and fatty acid ω-hydroxylase activities.

Authors:  Katheryne Z Edson; Allan E Rettie
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.